Amgen (AMGN) is a publicly traded Healthcare sector company. As of August 8, 2026, AMGN trades at $409.12 with a market cap of $219.02B and a P/E ratio of 25.18. AMGN moved +1.50% today. Year to date, AMGN is +25.43%; over the trailing twelve months it is +44.34%. Its 52-week range spans $253.30 to $418.40. Analyst consensus is buy with an average price target of $360.52. Rallies surfaces AMGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Amgen (AMGN) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. AMGN moved +1.50% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $409.12 |
| Market Cap | $219.02B |
| P/E Ratio | 25.18 |
| EPS | $16.22 |
| Dividend Yield | 2.52% |
| 52-Week High | $418.40 |
| 52-Week Low | $253.30 |
| Volume | 1.02M |
| Avg Volume | 0 |
| Revenue (TTM) | $38.09B |
| Net Income | $8.74B |
| Gross Margin | 69.52% |
17 analysts cover AMGN: 0 strong buy, 7 buy, 9 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $360.52.